Acura Pharmaceuticals, Inc. (ACUR)

Market Cap	184.81K
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	66.00M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,050
Open	0.0500
Previous Close	0.0028
Day's Range	0.0028 - 0.0500
52-Week Range	0.0001 - 0.0500
Beta	49.27
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 28, 2020

About ACUR

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1935
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUR